# FDA Inspection 1202973 - Bioreliance Ltd. - June 30, 2022

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/e05c200b-75e5-4694-902b-d0c3fc75523b
Source feed: FDA_Inspections

> FDA Inspection 1202973 for Bioreliance Ltd. on June 30, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202973
- Company Name: Bioreliance Ltd.
- Inspection Date: 2022-06-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1223799 - 2023-11-07](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/ad89b2f2-8a1e-42f8-873f-e513868ccffc)
- [FDA Inspection 1088154 - 2019-03-21](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/b50e7b96-afd3-494e-b2cf-716caad515c2)
- [FDA Inspection 1066803 - 2017-10-10](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/e568873a-4e39-4347-a90b-26dfacf4c332)
- [FDA Inspection 976603 - 2016-03-17](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/7702d229-c198-472b-981d-5b80a636b40d)
- [FDA Inspection 890477 - 2014-07-18](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/060c5afd-85fb-473e-b010-1b441f9495e5)

Company: https://www.keypedia.com/companies/bioreliance-ltd/0c15a584-09c6-4b3f-bb0e-5ac66b915aa1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c